1-16251340-A-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_018994.3(FBXO42):c.1484T>A(p.Leu495Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018994.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO42 | NM_018994.3 | c.1484T>A | p.Leu495Gln | missense_variant | Exon 10 of 10 | ENST00000375592.8 | NP_061867.1 | |
FBXO42 | XM_047422747.1 | c.1484T>A | p.Leu495Gln | missense_variant | Exon 12 of 12 | XP_047278703.1 | ||
FBXO42 | XM_047422750.1 | c.1484T>A | p.Leu495Gln | missense_variant | Exon 12 of 12 | XP_047278706.1 | ||
FBXO42 | XM_047422751.1 | c.1484T>A | p.Leu495Gln | missense_variant | Exon 12 of 12 | XP_047278707.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO42 | ENST00000375592.8 | c.1484T>A | p.Leu495Gln | missense_variant | Exon 10 of 10 | 1 | NM_018994.3 | ENSP00000364742.3 | ||
FBXO42 | ENST00000444116.1 | c.638T>A | p.Leu213Gln | missense_variant | Exon 4 of 4 | 5 | ENSP00000412416.1 | |||
FBXO42 | ENST00000456164.5 | c.638T>A | p.Leu213Gln | missense_variant | Exon 3 of 3 | 2 | ENSP00000415663.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1484T>A (p.L495Q) alteration is located in exon 10 (coding exon 9) of the FBXO42 gene. This alteration results from a T to A substitution at nucleotide position 1484, causing the leucine (L) at amino acid position 495 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at